Cellares

Cellares is the world's first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing. The company is revolutionizing the industry by replacing manual, labor-intensive manufacturing with an automated 'Smart Factory' model. Their proprietary technology, the Cell Shuttle, is a fully automated, end-to-end manufacturing platform designed to meet global patient demand while significantly reducing costs and process failure rates. Cellares provides a vertically integrated solution across technology development, biopharmaceutical contract manufacturing, and consumables manufacturing. By leveraging high-throughput automation, the company claims to achieve a tenfold increase in productivity and up to a 70% reduction in per-patient manufacturing costs compared to conventional CDMO facilities. Their platform supports a wide range of cell therapy modalities, including CAR-T, TCR-T, and gene-edited stem cells.